Taro Annual Report on Form 20-F Available for Fiscal Year Ended March 31, 2017

HAWTHORNE, N.Y.--()--Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2017, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro’s website at www.taro.com.

Hard copies of the report may be ordered free of charge by sending requests to:

Taro Pharmaceuticals U.S.A., Inc.
Three Skyline Drive
Hawthorne, NY 10532
attention: William J. Coote or
via email to William.Coote@Taro.com

Additionally, the report may be accessed on the SEC’s website at www.sec.gov.

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.

Contacts

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer, 914-345-9001
VP, CFO
Mariano.Balaguer@taro.com
or
William J. Coote, 914-345-9001
AVP, Business Finance, Treasurer and Investor Relations
William.Coote@taro.com

Recent Stories

  • Taro Announces Joining of CEO
    September 01, 2017
    HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that Mr. Uday Baldota has joined the Company as its Chief Exe... more »
  • Taro Provides Results for Quarter Ended June 2017
    August 08, 2017
    HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 20... more »
  • View Press Release
    Taro to Announce First Quarter Results on August 8, 2017
    August 02, 2017
    HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2017, aft... more »
RSS feed for Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.